REDHILL BIOPHARMA LTD. Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2025-12-31: Form 6-K; Period of report 2025-12-31; Description 6-K; Document zk2534156.htm.
- 2025-12-23: Form 6-K; Period of report 2025-12-23; Description 6-K; Document zk2534128.htm.
- 2025-12-15: Form 6-K; Period of report 2025-12-15; Description 6-K; Document zk2534111.htm.
- 2025-12-01: Form 6-K; Period of report 2025-12-01; Description 6-K; Document zk2534077.htm.